NCT01385371View on ClinicalTrials.gov

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,501

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Rhinitis AllergicConjunctivitis

Interventions

BIOLOGICAL

Grass (Phleum pratense) pollen allergen extract

One dissolving tablet sublingually once daily

BIOLOGICAL

Placebo for SCH 697243

One dissolving tablet sublingually once daily

All Listed Sponsors

lead

ALK-Abelló A/S

INDUSTRY

NCT01385371 - A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) | Biotech Hunter | Biotech Hunter